Marketed new antiepileptic drugs: are they better than old-generation agents?

Author: PeruccaEmilio

Paper Details 
Original Abstract of the Article :
Until a decade ago, the pharmacologic armamentarium for the management of epilepsy was restricted to a little more than a handful of drugs that had been introduced 20 to 70 years earlier. This situation has changed dramatically, with as many as nine new-generation drugs (oxcarbazepine, gabapentin, l...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1097/00007691-200202000-00013

データ提供:米国国立医学図書館(NLM)

New Antiepileptic Drugs: Are They Better?

The development of new antiepileptic drugs (AEDs) has revolutionized the management of epilepsy. This review article examines the efficacy and safety of newer-generation AEDs compared to older-generation agents.

The Advancement of Antiepileptic Therapy

The authors highlight the significant progress made in antiepileptic therapy with the introduction of newer drugs. While these newer AEDs offer improved tolerability, ease of use, and reduced interaction potential, their efficacy in truly refractory epilepsy may not be superior to older agents.

Considerations for Antiepileptic Drug Choice

This research underscores the importance of carefully considering the individual needs of patients with epilepsy when selecting AEDs. The authors emphasize the need for clinicians to have adequate knowledge of the indications, contraindications, and modes of use of newer AEDs to ensure optimal treatment and minimize potential risks.

Dr.Camel's Conclusion

This review provides a valuable overview of the evolving landscape of antiepileptic therapy, emphasizing the importance of balancing the benefits and risks of various AEDs. Like a camel searching for the best path through the desert, clinicians must navigate the complex world of epilepsy treatment with careful consideration of the individual needs of their patients.

Date :
  1. Date Completed 2002-04-23
  2. Date Revised 2019-09-06
Further Info :

Pubmed ID

11805726

DOI: Digital Object Identifier

10.1097/00007691-200202000-00013

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.